Molecular Biology Reports

, Volume 40, Issue 7, pp 4147–4151 | Cite as

XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population



Previous studies investigating the association between X-ray repair cross-complementation group 1 (XRCC1) Arg399Gln polymorphism and colorectal cancer risk in Chinese provided inconsistent findings. To assess the association in Chinese population, a meta-analysis was performed. Eligible studies were searched in Pubmed, Emabse, and China National Knowledge Infrastructure databases. Odds ratios (OR) with the corresponding 95 % confidence intervals (95 %CI) were pooled to assess the association. Seven case–control studies involving a total of 2136 colorectal cancer cases and 3168 controls were finally included in the meta-analysis. Our analysis suggested that the variant genotypes of XRCC1 Arg399Gln were associated with an increased risk of colorectal cancer in Chinese population (Gln vs. Arg: random effect model OR = 1.24, 95 %CI = 1.01–1.52, P = 0.041; GlnGln vs. ArgArg: random effect model OR = 1.52, 95 %CI = 1.07–2.15, P = 0.019; and Recessive model: fixed effect model OR = 1.37, 95 %CI = 1.12–1.67, P = 0.002). There was low risk of publication bias in present meta-analysis. Our meta-analysis provides an evidence for the association between XRCC1 Arg399Gln polymorphism and colorectal cancer risk in Chinese population, and XRCC1 Arg399Gln variant genotypes contribute to increased risk of colorectal cancer in Chinese.


XRCC1 Colorectal cancer Polymorphism Meta-analysis 


Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRefGoogle Scholar
  2. 2.
    Ballinger AB, Anggiansah C (2007) Colorectal cancer. BMJ 335:715–718PubMedCrossRefGoogle Scholar
  3. 3.
    Cunningham D, Atkin W, Lenz HJ et al (2010) Colorectal cancer. Lancet 375:1030–1047PubMedCrossRefGoogle Scholar
  4. 4.
    Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359:2143–2153PubMedCrossRefGoogle Scholar
  5. 5.
    Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361:2449–2460PubMedCrossRefGoogle Scholar
  6. 6.
    Jalal S, Earley JN, Turchi JJ (2011) DNA repair: from genome maintenance to biomarker and therapeutic target. Clin Cancer Res 17:6973–6984PubMedCrossRefGoogle Scholar
  7. 7.
    Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874–897PubMedCrossRefGoogle Scholar
  8. 8.
    Butkiewicz D, Rusin M, Sikora B et al (2011) An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep 38:5231–5241PubMedCrossRefGoogle Scholar
  9. 9.
    Dai L, Duan F, Wang P et al (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep 39:9535–9547PubMedCrossRefGoogle Scholar
  10. 10.
    Huang J, Zhang J, Zhao Y et al (2011) The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep 38:4565–4573PubMedCrossRefGoogle Scholar
  11. 11.
    Jin MJ, Chen K, Zhang Y et al (2007) Correlations of single nucleotide polymorphisms of DNA repair gene XRCC1 to risk of colorectal cancer. Ai Zheng 26:274–279PubMedGoogle Scholar
  12. 12.
    Zhao Y, Deng X, Wang Z et al (2012) Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pac J Cancer Prev 13:665–669PubMedCrossRefGoogle Scholar
  13. 13.
    Zhu C, Zhang Y, Bao Q et al (2011) The study on the relationship between XRCC1 gene polymorphisms and the susceptibility of colorectal cancer [Article in Chinese]. Chin J Digest 31:450–454Google Scholar
  14. 14.
    Huang S, Yi B, Yang XH et al (2010) Polymorphisms of DNA repair gene XRCC1 and genetic susceptibility to colorectal cancer [Article in Chinese]. Chin J Exp Surg 27:1057–1059Google Scholar
  15. 15.
    Ren Z, Fan JW, Zhou CZ et al (2007) Association between XRCC1 SNP and susceptibility to sporadic colorectal carcinoma [Article in Chinese]. Chin J Exp Surg 24:1087–1089Google Scholar
  16. 16.
    Yeh CC, Sung FC, Tang R et al (2007) Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci 14:183–193PubMedCrossRefGoogle Scholar
  17. 17.
    Song HN, Liu XL, YX E (2008) The correlative study of the XRCC1 gene haplotype and risk of colorectal cancer in China [Article in Chinese]. J Qiqihar Med Coll 29:2957–2960Google Scholar
  18. 18.
    Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCrossRefGoogle Scholar
  19. 19.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  20. 20.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  21. 21.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRefGoogle Scholar
  22. 22.
    Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedCrossRefGoogle Scholar
  23. 23.
    Gsur A, Bernhart K, Baierl A et al (2011) No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol 35:38–41CrossRefGoogle Scholar
  24. 24.
    Wang B, Wang D, Huang G et al (2010) XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 25:313–321PubMedCrossRefGoogle Scholar
  25. 25.
    Kumar A, Pant MC, Singh HS et al (2012) Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India. Tumour Biol 33:111–119PubMedCrossRefGoogle Scholar
  26. 26.
    Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8:180–192PubMedCrossRefGoogle Scholar
  27. 27.
    Tomkinson AE, Chen L, Dong Z et al (2001) Completion of base excision repair by mammalian DNA ligases. Prog Nucleic Acid Res Mol Biol 68:151–164PubMedCrossRefGoogle Scholar
  28. 28.
    Weinfeld M, Mani RS, Abdou I et al (2011) Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repair. Trends Biochem Sci 36:262–271PubMedCrossRefGoogle Scholar
  29. 29.
    Ding J, Miao ZH, Meng LH et al (2006) Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci 27:338–344PubMedCrossRefGoogle Scholar
  30. 30.
    Liu Y, Zhou W, Zhong DW (2012) Meta-analyses of the associations between four common TGF-beta1 genetic polymorphisms and risk of colorectal tumor. Tumour Biol 33:1191–1199PubMedCrossRefGoogle Scholar
  31. 31.
    Nagasubramanian R, Innocenti F, Ratain MJ (2003) Pharmacogenetics in cancer treatment. Annu Rev Med 54:437–452PubMedCrossRefGoogle Scholar
  32. 32.
    Wu J, Liu J, Zhou Y et al (2012) Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis. Clin Cancer Res 18:3972–3981PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Department of General SurgeryShengjing Hospital of China Medical UniversityShenyangChina
  2. 2.Department of GastroenterologyThe First Affiliated Hospital of China Medical UniversityShenyangChina

Personalised recommendations